POMDOCTOR Shareholders Approve ADR Termination and 10-to-1 Reverse Split
POM sits 72% above its 52-week low of $0.5 on light trading volume (0.1× avg).
Summary
POMDOCTOR shareholders approved terminating the ADR program and a 10-to-1 reverse split, enabling a direct Nasdaq listing of ordinary shares. The consolidation will reduce shares outstanding from 27.8M to about 2.78M.
Key Events · Corporate Governance and Compliance · POM
-
ADR Termination Approved
Shareholders approved terminating the ADR program and directly listing Class A ordinary shares on Nasdaq, with 45,395,656 votes for and 34,398 against.
-
10-to-1 Reverse Split Approved
A 10-to-1 share consolidation was approved, reducing outstanding shares from 27,802,964 to approximately 2,780,296 and cutting authorized share capital from 500M to 50M shares.
-
Nasdaq Compliance Strategy
The reverse split will mechanically raise the per-share price, supporting the $1.00 minimum bid requirement after the company regained compliance in July 2026.
-
Financial Distress Context
The vote follows a September 29 going-concern warning and RMB238.2M H1 2026 net loss, with cash insufficient to cover near-term obligations.
Analysis · POM · Trade & Services
Shareholders approved both the ADR program termination and a 10-to-1 share consolidation, clearing the path for a direct Nasdaq listing of ordinary shares. The reverse split reduces outstanding shares from 27.8M to approximately 2.78M, which will mechanically raise the per-share price — a critical step for maintaining Nasdaq's $1.00 minimum bid requirement after the company's recent going-concern warning and RMB238.2M H1 2026 net loss. The vote was overwhelmingly in favor, with over 45M votes supporting each proposal against negligible opposition.
How filings like this one have moved
In the 30 days to Oct 2, 2026, 29.5% of the 1629 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.59%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, POM was trading at $0.86 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $7.1M. The 52-week trading range was $0.50 to $115.74. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.